click enter text
long time come amazon get drug deliveri
news amazon morn announc acquir pillpack
undisclos sum pillpack deliv medic pre-sort dose
packag handl logist refil renew pillpack hold
pharmaci licens state appropri accredit
in-network pbm includ medicar part plan servic
free ship free custom respons copay
take long-written believ amazon would enter
pharmaceut deliveri space pharmaci factor
incorpor outlook upgrad
rais outperform well analyz amazon privat label basic
offer over-the-count gener drug privat label anoth
way enhanc profit acquisit pillpack seem fit perfectli
amazon strateg perspect pillpack alreadi licens
state allow amazon leapfrog regulatori hurdl
alreadi logist system place deliv person drug
packag direct consum believ program like
integr prime also pillpack appear us appeal
servic medicar popul may difficult time
get drug store even sort multipl medic
pillpack remov logist challeng get pharmaci well
simplifi daili dosag pre-sort
key issu move amazon get drug deliveri
certainli pose signific threat drug store also
challeng groceri store larg in-stor pharmaci drug
deliveri around time partner usp
challeng deal amazon go bundl
good servic prime benefit ecosystem bring
estim prime membership around million household
mani way prime consum demograph
research suggest consum engag amazon frequent
fresh food pharmaci like
increasingli shift purchas decis product categori
amazon view acquisit pillpack bullish
reiter outperform rate view news quit neg
drug store well supermarket
reiter under-perform rate kr
price et
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
analyst wolf research llc primarili respons research report whose name appear first front page
research report herebi certifi recommend opinion express research report accur reflect research
analyst person view subject secur issuer ii part research analyst compens
directli indirectli relat specif recommend view contain report
price chart rate target price histori
page
wolf research llc fundament recommend rate price risk
risk may imped achiev recommend rate target price
govern action execut misstep consum impact sale profit
page
increas invest spend and/or execut misstep distribut impact sale
profit increas competit slow revenu growth valuat amazon rich
convent measur growth certain intern market could continu
pressur profit price pressur aw capit disciplin data secur
risk upsid equiti valuat histor averag win
larg pbm contract strong manag team focus
return organ stronger growth produc signific cash flow
focus enhanc sharehold return announc acquisit aetna lead
stronger growth profit combin basi risk downsid growth
profit outlook pro forma cvs/aet enterpris lower-than-anticip
diminish compani vertic model advantag increas government
involv healthcar industri amazon enter prescript drug dispens
market market share volum gain particularli health plan client
materi enterpris profit growth less-than-anticip industri becom
competit increas reimburs pressur unexpect loss larg pbm
tax reform lead stronger-than-anticip consum spend stapl retail
back aggress price stanc competit climat abat
kroger busi invest restock kroger plan lead stronger busi
risk upsid wba acquisit certain store creat market power
could posit implic sale profit
manag team solid track record enhanc profit well
integr acquisit continu could lead higher profit
earn save initi synergi greater-than-expect lead
higher profit earn make acquisit significantli enhanc
sharehold valu amazon enter pharmaceut dispens market risk
downsid amazon decid enter pharmaceut dispens market
chang consum landscap around purchas prefer lead lower sale
profit compani pharmacy-rel reimburs pressur reduc
profit anticip long-term viabil drugstor wane
particularli lead reduc sale profit walgreen given
larg store base compani equiti valuat move lower drugstor
model becom less favor channel consum shop goods/ prescript
compani lower rel busi transpar lead contract
earn multipl result reduct equiti price wba global footprint
creat less visibl wba oper also expos compani geopolit
shock compani higher-cost horizont model lead weaken competit
posit long-term rel peer vertically-ori
risk upsid benefit lower corpor tax rate
consum spend greater depict investor continu see wal-mart
survivor build e-commerc juggernaut look sluggish
oper perform sustain stronger comp sale growth
abl garner stronger-than-expect market share signific abat sg
re-establish price gap grocery/consum without materi
profit impact corpor action divestitur spin-off risk
downsid walmart push e-commerc without risk walmart e-commerc
loss increas need greater earn supercent busi wmt
valuat remain expens would argu difficult justifi tax reform spur less
overal econom benefit lead less-than-anticip consum spend comp
sale growth slow walmart supercent mix align consum
